Skip to main content
Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · Real-Time Price · USD
0.3186
+0.0053 (1.69%)
At close: Jun 6, 2025, 4:00 PM
0.3100
-0.0086 (-2.70%)
After-hours: Jun 6, 2025, 7:57 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20
Novel Therapeutics
391.70K
Log In
Log In
Log In
Novel Therapeutics Growth
-73.93%
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20
United States
391.70K
Log In
Log In
Log In
United States Growth
-73.93%
Log In
Log In
Log In